Soleno Therapeutics Inc (SLNO)

P/OCF Ratio

26.12×

TTM · Retrieved:

SLNO logo

SLNO P/OCF Ratio

Current (TTM)26.12×
SLNO Quarterly P/OCF Ratio (13.04× → 67.13×)
High-resolution chart · PNG

SLNO p/ocf ratio history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Soleno Therapeutics Inc P/OCF Ratio — Quarterly
Period endingP/OCF Ratio
67.1289×
50.551×
82.6224×
-335.4608×
-100.7416×
-82.2984×
-141.6637×
-92.5573×
-119.9142×
-167.9756×
-53.3004×
-40.17×
-15.0248×
-18.1722×
-16.8896×
-28.0986×
-14.0453×
-23.865×
-68.2883×
-56.7279×
-67.0509×
-111.8716×
-162.0327×
-78.5463×
-93.9548×
-119.2158×
-50.5297×
-110.1949×
-83.1154×
-51.619×
-90.8699×
-86.5606×
-70.2677×
-64.3395×
-55.3575×
-43.1277×
-41.3916×
-40.4603×
-25.4582×
-22.294×
-22.0802×
-40.5124×
-37.0228×
-46.9235×
-123.2146×
-32.4456×
-20.5265×
-23.5045×
-53.3629×
-37.6353×
-29.4138×
-20.5323×
13.037×
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.